SCHEMBL5049537

SCHEMBL5049537

Cn1ncc(-c2ccc(Cl)c(Cl)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.45
KCNH2 Q12809 3/20 0.43
KMO O15229 5/20 0.42
F2RL3 Q96RI0 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD11B1 P28845 1/20 0.40
CYP1B1 Q16678 1/20 0.39
ABL1 P00519 1/20 0.39
BRD4 O60885 1/20 0.39
BRD3 Q15059 1/20 0.39
NPC1 O15118 2/20 0.38
NFKB1 P19838 2/20 0.38
RAB9A P51151 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5048013 0.79 AOC3 (0.43) KCNH2MAPTNPC1NFKB1RAB9A
SCHEMBL27570607 0.79 AHR (0.45) AHRKCNH2KMOF2RL3CYP1A2
SCHEMBL14648841 0.74 KEAP1 (0.53) AHRKCNH2KMOF2RL3CYP1A2
SCHEMBL29598873 0.74 KEAP1 (0.53) AHRKCNH2KMOF2RL3CYP1A2
SCHEMBL31168042 0.74 CHRM2 (0.38) BRD4BRD3AOC3
SCHEMBL17809711 0.72 KCNH2 (0.45) KCNH2KMOHSD11B1BRD4BRD3
SCHEMBL5053616 0.72 AOC3 (0.47) KCNH2MAPTBRD4BRD3NPC1
Ammonia Solution, Strong SCHEMBL28862485 0.72 AOC3 (0.43) CYP1A2CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL3223296 0.71 KMT2A (0.49) AHRKMOF2RL3MAPTNPC1
SCHEMBL25732008 0.71 IDO1 (0.49) KMONPC1NFKB1RAB9ANFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed